Evidence map›Paper›PMID 31292262›Full record

ArticleScience translational medicine2019

Autoimmune receptor encephalitis in mice induced by active immunization with conformationally stabilized holoreceptors.

Brian E Jones, Kenneth R Tovar, April Goehring, Farzad Jalali-Yazdi, Nana J Okada, Eric Gouaux, Gary L Westbrook

Registry-linked trialAbstract read
In one paragraph

Article in Science translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04372615 (A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-Nmda Receptor Encephalitis and Assess Markers of Disease), which is not on this map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04372615 phase2recruitingnot on this mapstarted 2022, after this paper: background citation

A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-Nmda Receptor Encephalitis and Assess Markers of Disease

TypeinterventionalSponsorUniversity of UtahRan2022 to 2028Enrolled116ConditionsAutoimmune Encephalitis, EncephalitisArmsInebilizumab, Placebo
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Single-Cell Profiling Reveals Clonally Expanded CX3CR1Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Antibody-Mediated Mechanisms in Autoimmune Neurological Disorders.The European journal of neuroscience · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. [Association Between T Lymphocyte Mitochondrial Function and Disease Activity in Anti-NMDAR Encephalitis].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Article
  8. Article
  9. Review
  10. Autoimmune neuropsychiatric disorders manifesting with psychosis.The Journal of clinical investigation · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Brian E JonesVollum Institute, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.ORCID 0000-0002-9718-9035
Kenneth R TovarVollum Institute, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.ORCID 0000-0001-5656-8525
April GoehringVollum Institute, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.ORCID 0000-0002-2592-6956
Farzad Jalali-YazdiVollum Institute, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.ORCID 0000-0002-0291-3482
Nana J OkadaVollum Institute, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.ORCID 0000-0003-4668-931X
Eric GouauxVollum Institute, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.ORCID 0000-0002-8549-2360
Gary L WestbrookVollum Institute, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA. westbroo@ohsu.edu.ORCID 0000-0002-8108-5223
Oregon Health & Science University · US

Funding

3D STRUCTURE/FUNCTION OF LIGAND GATED ION CHANNELSR01NS038631 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI GOUAUX, JAMES E · 1999 to 2024
$6.7M
Ultrastructure and Single Particle Microscopy CoreP30NS061800 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI AICHER, SUE A · 2009 to 2020
$6.6M
3D Structure and Function of Ligand-Gated Ion ChannelsR37NS038631 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI James E Gouaux · 2009 to 2026
$4.1M
Transcriptional analysis of adult newborn hippocampal neuronsR01NS080979 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI GOODMAN, RICHARD H. · 2013 to 2016
$1.3M
Howard Hughes Medical InstituteNINDS NIH HHS P30 NS061800NINDS NIH HHS R01 NS038631NINDS NIH HHS R01 NS080979NINDS NIH HHS R37 NS038631
6 · The paper itself

Abstract

Autoimmunity to membrane proteins in the central nervous system has been increasingly recognized as a cause of neuropsychiatric disease. A key recent development was the discovery of autoantibodies to

Indexed as

AnimalsAutoantibodiesBehavior, AnimalB-LymphocytesBrainEncephalitisHashimoto DiseaseHEK293 CellsHumansImmunoglobulin GInflammationLeukocytesMiceNeurogliaNeuronsProtein ConformationAutoantibodiesImmunoglobulin GProteolipidsproteoliposomesReceptors, N-Methyl-D-Aspartate

Identifiers

PMID31292262
PMCPMC6729143
OpenAlexW2960853637

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.